Trial · NCT03000673
Results by group340
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 340
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment B | Adverse Events | 4 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment C | Adverse Events | 4 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment D | Adverse Events | 3 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment A | Adverse Events | 2 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment B | Serious Adverse Events | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment C | Serious Adverse Events | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment D | Serious Adverse Events | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment A | Serious Adverse Events | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment B | Adverse Events Leading to Discontinuations | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment C | Adverse Events Leading to Discontinuations | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment D | Adverse Events Leading to Discontinuations | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment A | Adverse Events Leading to Discontinuations | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment B | Deaths | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment C | Deaths | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment D | Deaths | 0 | Participants | |
| The Number of Adverse Events (AEs), Serious AEs (SAEs), AEs Leading to Discontinuation and Death | Treatment A | Deaths | 0 | Participants | |
| The Number of Participants Marked Abnormalities in Clinical Laboratory Tests : Hematology I; Hematology II; Coagulation | Treatment B | Hematology I Hemoglobin (G/DL) Abnormal low | 3 | Participants | |
| The Number of Participants Marked Abnormalities in Clinical Laboratory Tests : Hematology I; Hematology II; Coagulation | Treatment C | Hematology I Hemoglobin (G/DL) Abnormal low | 3 | Participants | |
| The Number of Participants Marked Abnormalities in Clinical Laboratory Tests : Hematology I; Hematology II; Coagulation | Treatment D | Hematology I Hemoglobin (G/DL) Abnormal low | 2 | Participants | |
| The Number of Participants Marked Abnormalities in Clinical Laboratory Tests : Hematology I; Hematology II; Coagulation | Treatment A | Hematology I Hemoglobin (G/DL) Abnormal low | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03000673/results